Glucagon Manufacturing In PLI Scheme: The government decided to manufacture a Glucagon-like peptide receptor agonist (GLP-1RA) drug in India under the Production Linked Incentive (PLI) scheme from 2026. GLP-1RA is a class of anti-diabetic drugs which are also used for weight loss. Apart from GLP-1RA, investors are planning to make other drugs like Ozempic (for […]
Apps
